These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 26440500)

  • 1. Advancing Pharmacogenomics as a Component of Precision Medicine: How, Where, and Who?
    Johnson JA; Weitzel KW
    Clin Pharmacol Ther; 2016 Feb; 99(2):154-6. PubMed ID: 26440500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics to achieve precision medicine.
    Empey PE
    Am J Health Syst Pharm; 2016 Dec; 73(23):1906-1907. PubMed ID: 27784662
    [No Abstract]   [Full Text] [Related]  

  • 3. The Daniel K. Inouye College of Pharmacy Scripts: Precision Medicine Through the Use of Pharmacogenomics: Current Status and Barriers to Implementation.
    Ciarleglio AE; Ma C
    Hawaii J Med Public Health; 2017 Sep; 76(9):265-269. PubMed ID: 28900583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of pharmacogenetics in public health and clinical health care: a SWOT analysis.
    Kapoor R; Tan-Koi WC; Teo YY
    Eur J Hum Genet; 2016 Dec; 24(12):1651-1657. PubMed ID: 27577547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of a multidisciplinary pharmacogenomics clinic in a community health system.
    Dunnenberger HM; Biszewski M; Bell GC; Sereika A; May H; Johnson SG; Hulick PJ; Khandekar J
    Am J Health Syst Pharm; 2016 Dec; 73(23):1956-1966. PubMed ID: 27864203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementing personalized medicine: development of a cost-effective customized pharmacogenetics genotyping array.
    Johnson JA; Burkley BM; Langaee TY; Clare-Salzler MJ; Klein TE; Altman RB
    Clin Pharmacol Ther; 2012 Oct; 92(4):437-9. PubMed ID: 22910441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the current level of pharmacists' pharmacogenomics knowledge and its impact on pharmacogenomics implementation.
    Nagy M; Tsermpini EE; Siamoglou S; Patrinos GP
    Pharmacogenomics; 2020 Nov; 21(16):1179-1189. PubMed ID: 33118449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current practices in the delivery of pharmacogenomics: Impact of the recommendations of the Pharmacy Practice Model Summit.
    Valgus J; Weitzel KW; Peterson JF; Crona DJ; Formea CM
    Am J Health Syst Pharm; 2019 Apr; 76(8):521-529. PubMed ID: 31361863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacists Leading the Way to Precision Medicine: Updates to the Core Pharmacist Competencies in Genomics.
    Gammal RS; Lee YM; Petry NJ; Iwuchukwu O; Hoffman JM; Kisor DF; Empey PE
    Am J Pharm Educ; 2022 Apr; 86(4):8634. PubMed ID: 34301570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of hospital pharmacists in the adoption and use of pharmacogenomics and precision medicine.
    Schwartz EJ; Issa AM
    Per Med; 2017 Jan; 14(1):27-35. PubMed ID: 29749827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inaugural Pharmacogenomics Access and Reimbursement Symposium.
    Rogers SL; Patrinos GP; Mitropoulou C; Formea CM; Jones JS; Brown BG
    Pharmacogenomics; 2021 Jun; 22(9):515-517. PubMed ID: 34032472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Implementation of Pharmacogenomics for Personalized Precision Medicine: Barriers and Solutions.
    Klein ME; Parvez MM; Shin JG
    J Pharm Sci; 2017 Sep; 106(9):2368-2379. PubMed ID: 28619604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for implementation of an effective pharmacogenomics program in pharmacy education.
    Rao US; Mayhew SL; Rao PS
    Pharmacogenomics; 2015 Jul; 16(8):905-11. PubMed ID: 26067487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PARC report: health outcomes and value of personalized medicine interventions: impact on patient care.
    Mitropoulou C; Litinski V; Kabakchiev B; Rogers S; P Patrinos G
    Pharmacogenomics; 2020 Jul; 21(11):797-807. PubMed ID: 32635813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precision medicine: a call for increased pharmacogenomic education.
    Ta R; Cayabyab MA; Coloso R
    Per Med; 2019 May; 16(3):233-245. PubMed ID: 31025601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next Decade.
    Alessandrini M; Chaudhry M; Dodgen TM; Pepper MS
    OMICS; 2016 Oct; 20(10):593-603. PubMed ID: 27643672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics: bridging the gap between science and practice.
    Lee KC; Ma JD; Kuo GM
    J Am Pharm Assoc (2003); 2010; 50(1):e1-14; quiz e15-7. PubMed ID: 20368146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics--how close/far are we to practising individualized medicine for children?
    Sing CW; Cheung CL; Wong IC
    Br J Clin Pharmacol; 2015 Mar; 79(3):419-28. PubMed ID: 25855823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomics: paving the path to personalized medicine.
    Patrinos GP; Innocenti F
    Pharmacogenomics; 2010 Feb; 11(2):141-6. PubMed ID: 20136354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of a pharmacogenomics education program for pharmacists.
    Formea CM; Nicholson WT; Vitek CR; Wix KK; McCullough KB; Cunningham JL; Zeuli JD; Matey ET; Merten JA; Richardson DM; Billings AL; Schramm GE
    Am J Health Syst Pharm; 2018 Dec; 75(23):1939-1946. PubMed ID: 30301720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.